Advanced search
Publication Cover
Molecular and Cellular Biology Volume 18, 1998 - Issue 12
Submit an article Journal homepage
34
Views
345
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors

Bart Lutterbacha Department of Biochemistry;b Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee37232
,
Jennifer J. Westendorfa Department of Biochemistry;b Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee37232
,
Bryan Linggia Department of Biochemistry;b Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee37232
,
Andrea Pattena Department of Biochemistry;b Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee37232
,
Mariko Moniwac Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, ManitobaR3E 0W3, Canada
,
James R. Daviec Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, ManitobaR3E 0W3, Canada
,
Khanh D. Huynhd Biochemistry, Molecular Biology and Biophysics Graduate Program
,
Vivian J. Bardwelld Biochemistry, Molecular Biology and Biophysics Graduate Program;e Department of Biochemistry, Institute of Human Genetics and Cancer Center, University of Minnesota, Minneapolis, Minnesota55455
,
Robert M. Lavinskyf Howard Hughes Medical Institute
,
Michael G. Rosenfeldf Howard Hughes Medical Institute;g Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California92093-0648
,
Christopher Glassg Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California92093-0648
,
Edward Setoh H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida33612
&
Scott W. Hieberta Department of Biochemistry;b Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee37232Correspondence[email protected]
 show all
Pages 7176-7184 | Received 16 Jul 1998, Accepted 27 Aug 1998, Published online: 28 Mar 2023

Citations (345)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (31)

Hong Nguyen, Jolene Mariotti, Diana Bareyan, Robert H Carnahan, Tracy Cooper, Christopher S Williams & Michael E Engel. (2015) Anti-MTG16 antibodies reveal MTG16 subcellular distribution and nucleocytoplasmic transport in erythroleukemia cells. Antibody Technology Journal 5, pages 27-41.
Read now
Srividya Bhaskara. (2015) Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers. Cell Cycle 14:12, pages 1779-1785.
Read now
Aubrey Hunt, Melissa Fischer, Michael E. Engel & Scott W. Hiebert. (2011) Mtg16/Eto2 Contributes to Murine T-Cell Development. Molecular and Cellular Biology 31:13, pages 2544-2551.
Read now
Vanessa Gobert, Dani Osman, Stéphanie Bras, Benoit Augé, Muriel Boube, Henri-Marc Bourbon, Thomas Horn, Michael Boutros, Marc Haenlin & Lucas Waltzer. (2010) A Genome-Wide RNA Interference Screen Identifies a Differential Role of the Mediator CDK8 Module Subunits for GATA/ RUNX-Activated Transcription in Drosophila. Molecular and Cellular Biology 30:11, pages 2837-2848.
Read now
Michael E. Engel, Hong N. Nguyen, Jolene Mariotti, Aubrey Hunt & Scott W. Hiebert. (2010) Myeloid Translocation Gene 16 (MTG16) Interacts with Notch Transcription Complex Components To Integrate Notch Signaling in Hematopoietic Cell Fate Specification. Molecular and Cellular Biology 30:7, pages 1852-1863.
Read now
Chun Guo, Qiande Hu, Chunxia Yan & Jinsong Zhang. (2009) Multivalent Binding of the ETO Corepressor to E Proteins Facilitates Dual Repression Controls Targeting Chromatin and the Basal Transcription Machinery. Molecular and Cellular Biology 29:10, pages 2644-2657.
Read now
Brenda J. Chyla, Isabel Moreno-Miralles, Melissa A. Steapleton, Mary Ann Thompson, Srividya Bhaskara, Michael Engel & Scott W. Hiebert. (2008) Deletion of Mtg16, a Target of t(16;21), Alters Hematopoietic Progenitor Cell Proliferation and Lineage Allocation. Molecular and Cellular Biology 28:20, pages 6234-6247.
Read now
Daniela Salat, Robert Liefke, Jörg Wiedenmann, Tilman Borggrefe & Franz Oswald. (2008) ETO, but Not Leukemogenic Fusion Protein AML1/ETO, Augments RBP-Jκ/SHARP-Mediated Repression of Notch Target Genes. Molecular and Cellular Biology 28:10, pages 3502-3512.
Read now
Amy C. Moore, Joseph M. Amann, Christopher S. Williams, Emilios Tahinci, Tiffany E. Farmer, J. Andres Martinez, Genyan Yang, K. Scott Luce, Ethan Lee & Scott W. Hiebert. (2008) Myeloid Translocation Gene Family Members Associate with T-Cell Factors (TCFs) and Influence TCF-Dependent Transcription. Molecular and Cellular Biology 28:3, pages 977-987.
Read now
Si-Xuan Qian, Jian-yong Li, Min Hong, Hai-Rong Qiu, Lei Fan & Wei Xu. (2008) Acute myeloid leukemia in four patients with t(8;21) treated with all-trans retinoic acid as a single agent. Leukemia & Lymphoma 49:5, pages 998-1001.
Read now
Lotfy A. Mahmoud, Sameh S.A. Shamaa, Mohammad A. Salem, Doaa A. Aladle & Enas F.A. Goda. (2006) A study for evaluation of different diagnostic approaches in acute leukemia in Egypt. Hematology 11:2, pages 87-95.
Read now
Joseph M. Amann, Brenda J. Irvin Chyla, Tiffany C. Ellis, Andres Martinez, Amy C. Moore, Jeffrey L. Franklin, Laura McGhee, Shari Meyers, Joyce E. Ohm, K. Scott Luce, Andre J. Ouelette, M. Kay Washington, Mary Ann Thompson, Dana King, Shiva Gautam, Robert J. Coffey, Robert H. Whitehead & Scott W. Hiebert. (2005) Mtgr1 Is a Transcriptional Corepressor That Is Required for Maintenance of the Secretory Cell Lineage in the Small Intestine. Molecular and Cellular Biology 25:21, pages 9576-9585.
Read now
Francesco Piazza & Gianpietro Semenzato. (2004) Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction. Expert Review of Anticancer Therapy 4:3, pages 387-400.
Read now
Kristie L. Durst, Bart Lutterbach, Tanawan Kummalue, Alan D. Friedman & Scott W. Hiebert. (2003) The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain. Molecular and Cellular Biology 23:2, pages 607-619.
Read now
Joëlle Michaud, Hamish S. Scott & Robert Escher. (2003) AML1 Interconnected Pathways of Leukemogenesis. Cancer Investigation 21:1, pages 105-136.
Read now
Tanawan Kummalue, Jianrong Lou & Alan D. Friedman. (2002) Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBFβ-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein. Molecular and Cellular Biology 22:23, pages 8278-8291.
Read now
Cristina G. de Guzman, Alan J. Warren, Zheng Zhang, Larry Gartland, Paul Erickson, Harry Drabkin, Scott W. Hiebert & Christopher A. Klug. (2002) Hematopoietic Stem Cell Expansion and Distinct Myeloid Developmental Abnormalities in a Murine Model of the AML1-ETO Translocation. Molecular and Cellular Biology 22:15, pages 5506-5517.
Read now
Joseph M. Amann, John Nip, David K. Strom, Bart Lutterbach, Hironori Harada, Noel Lenny, James R. Downing, Shari Meyers & Scott W. Hiebert. (2001) ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain. Molecular and Cellular Biology 21:19, pages 6470-6483.
Read now
Franco Calabi, Richard Pannell & Gordana Pavloska. (2001) Gene Targeting Reveals a Crucial Role forMTG8 in the Gut. Molecular and Cellular Biology 21:16, pages 5658-5666.
Read now
Sebastien A. Burel, Nari Harakawa, Liming Zhou, Thomas Pabst, Daniel G. Tenen & Dong-Er Zhang. (2001) Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation. Molecular and Cellular Biology 21:16, pages 5577-5590.
Read now
Mukul Mathur, Philip W. Tucker & Herbert H. Samuels. (2001) PSF Is a Novel Corepressor That Mediates Its Effect through Sin3A and the DNA Binding Domain of Nuclear Hormone Receptors. Molecular and Cellular Biology 21:7, pages 2298-2311.
Read now
V. Sontini, A. Gozzini, B. Scappini, A. Grossi & P. Rossi Ferrini. (2001) Searching for the Magic Bullet Against Cancer: The Butyrate Saga. Leukemia & Lymphoma 42:3, pages 275-289.
Read now
Tokiko Nagamura-Inoue, Tomohiko Tamura & Keiko Ozato. (2001) Transcription Factors that Regulate Growth and Differentiation of Myeloid Cells. International Reviews of Immunology 20:1, pages 83-105.
Read now
Jinsong Zhang, Bruce A. Hug, Eric Y. Huang, Clarice W. Chen, Vania Gelmetti, Marco Maccarana, Saverio Minucci, Pier Giuseppe Pelicci & Mitchell A. Lazar. (2001) Oligomerization of ETO Is Obligatory for Corepressor Interaction. Molecular and Cellular Biology 21:1, pages 156-163.
Read now
Randy Fenrick, Lilin Wang, John Nip, Joseph M. Amann, Robert J. Rooney, Jennifer Walker-Daniels, Howard C. Crawford, Diana L. Hulboy, Michael S. Kinch, Lynn M. Matrisian & Scott W. Hiebert. (2000) TEL, a Putative Tumor Suppressor, Modulates Cell Growth and Cell Morphology of Ras-Transformed Cells While Repressing the Transcription of stromelysin-1. Molecular and Cellular Biology 20:16, pages 5828-5839.
Read now
Suming Huang & Stephen J. Brandt. (2000) mSin3A Regulates Murine Erythroleukemia Cell Differentiation through Association with the TAL1 (or SCL) Transcription Factor. Molecular and Cellular Biology 20:6, pages 2248-2259.
Read now
Ari M. Melnick, Jennifer J. Westendorf, Adam Polinger, Graeme W. Carlile, Sally Arai, Helen J. Ball, Bart Lutterbach, Scott W. Hiebert & Jonathan D. Licht. (2000) The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein. Molecular and Cellular Biology 20:6, pages 2075-2086.
Read now
Jürgen Krauter, Gerhard Heil & Arnold Ganser. (2000) The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease. Hematology 5:5, pages 369-381.
Read now
Randy Fenrick, Joseph M. Amann, Bart Lutterbach, Lilin Wang, Jennifer J. Westendorf, James R. Downing & Scott W. Hiebert. (1999) Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein. Molecular and Cellular Biology 19:10, pages 6566-6574.
Read now
Jinsong Zhang, Xiao Hu & Mitchell A. Lazar. (1999) A Novel Role for Helix 12 of Retinoid X Receptor in Regulating Repression. Molecular and Cellular Biology 19:9, pages 6448-6457.
Read now
Judith E Karp & Clarence B Sarkodee-Adoo. (1999) Acute progranulocytic leukaemia: a model for molecular medicine. Emerging Therapeutic Targets 3:1, pages 135-150.
Read now

Articles from other publishers (314)

Roland Windisch, Sophie Kreissig & Christian Wichmann. 2023. HDAC/HAT Function Assessment and Inhibitor Development. HDAC/HAT Function Assessment and Inhibitor Development 27 49 .
Kenichi Ishii, Matteo CorteseXubo LengMaxim N. ShokhirevKenta Asahina. (2022) A neurogenetic mechanism of experience-dependent suppression of aggression. Science Advances 8:36.
Crossref
Yi-Fan Zhang, Xiao-Lin Wang, Chun-Hui Xu, Na Liu, Ling Zhang, Yu-Ming Zhang, Yin-Yin Xie, Yuan-Liang Zhang, Qiu-Hua Huang, Lan Wang, Zhu Chen, Sai-Juan Chen, Robert G. Roeder, Shuhong Shen, Kai Xue & Xiao-Jian Sun. (2022) A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation. Frontiers in Cell and Developmental Biology 10.
Crossref
Yoshihiro Hayashi, Yuka Harada & Hironori Harada. (2022) Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective. Leukemia 36:5, pages 1203-1214.
Crossref
Tomofusa Fukuyama, Toshio Kitamura & Tomoko Kozu. (2022) UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8. International Journal of Hematology 115:5, pages 686-693.
Crossref
Gabriela Krivdova, Veronique Voisin, Erwin M. Schoof, Sajid A. Marhon, Alex Murison, Jessica L. McLeod, Martino M. Gabra, Andy G.X. Zeng, Stefan Aigner, Brian A. Yee, Alexander A. Shishkin, Eric L. Van Nostrand, Karin G. Hermans, Aaron C. Trotman-Grant, Nathan Mbong, James A. Kennedy, Olga I. Gan, Elvin Wagenblast, Daniel D. De Carvalho, Leonardo Salmena, Mark D. Minden, Gary D. Bader, Gene W. Yeo, John E. Dick & Eric R. Lechman. (2022) Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML. Cell Reports 38:10, pages 110481.
Crossref
Daniel T. Johnson, Amanda G. Davis, Jie-Hua Zhou, Edward D. Ball & Dong-Er Zhang. (2021) MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR. Experimental Hematology & Oncology 10:1.
Crossref
Nickolas Steinauer, Kevin Zhang, Chun Guo & Jinsong Zhang. (2021) Computational Modeling of Gene-Specific Transcriptional Repression, Activation and Chromatin Interactions in Leukemogenesis by LASSO-Regularized Logistic Regression. IEEE/ACM Transactions on Computational Biology and Bioinformatics 18:6, pages 2109-2122.
Crossref
Mahdieh Mehrpouri, Atieh Pourbagheri-Sigaroodi & Davood Bashash. (2021) The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies. International Immunopharmacology 100, pages 108114.
Crossref
Bon Q. TrinhSimone Ummarino, Yanzhou ZhangAlexander K. EbralidzeMahmoud A. Bassal, Tuan M. NguyenGerwin HellerRory CoffeyDanielle E. TenenEmiel van der KouweEmiliano Fabiani, Carmelo Gurnari, Chan-Shuo WuVladimir Espinosa Angarica, Henry YangSisi ChenHong ZhangAbby R. Thurm, Francisco Marchi, Elena Levantini, Philipp B. StaberPu ZhangMaria Teresa Voso, Pier Paolo PandolfiSusumu S. KobayashiLi Chai, Annalisa Di Ruscio & Daniel G. Tenen. (2021) Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML . Blood 138:15, pages 1331-1344.
Crossref
Snigdha Saikia, Uttariya Pal, Deep Jyoti Kalita, Avdhesh Kumar Rai, Anupam Sarma, Amal Chandra Kataki & Anil Mukund Limaye. (2021) RUNX1T1, a potential prognostic marker in breast cancer, is co-ordinately expressed with ERα, and regulated by estrogen receptor signalling in breast cancer cells. Molecular Biology Reports 48:7, pages 5399-5409.
Crossref
Katelyn E. Heimbruch, Alison E. Meyer, Puja Agrawal, Aaron D. Viny & Sridhar Rao. (2021) A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML. Neoplasia 23:3, pages 337-347.
Crossref
Kristy R. Stengel, Jacob D. Ellis, Clare L. Spielman, Monica L. Bomber & Scott W. Hiebert. (2021) Definition of a small core transcriptional circuit regulated by AML1-ETO. Molecular Cell 81:3, pages 530-545.e5.
Crossref
Laura E. Swart & Olaf Heidenreich. (2021) The RUNX1/RUNX1T1 network: translating insights into therapeutic options. Experimental Hematology 94, pages 1-10.
Crossref
Benedetto Daniele Giaimo, Ellen K. Gagliani, Rhett A. Kovall & Tilman Borggrefe. 2021. Notch Signaling in Embryology and Cancer. Notch Signaling in Embryology and Cancer 9 30 .
Tian He, Gary Wildey, Karen McColl, Alyssa Savadelis, Kyle Spainhower, Cassidy McColl, Adam Kresak, Aik Choon Tan, Michael Yang, Ata Abbas & Afshin Dowlati. (2020) Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer. Molecular Oncology 15:1, pages 195-209.
Crossref
Anne-Marie Landry-Voyer, Danny Bergeron, Carlo Yague-Sanz, Breac Baker & Francois Bachand. (2020) PDCD2 functions as an evolutionarily conserved chaperone dedicated for the 40S ribosomal protein uS5 (RPS2). Nucleic Acids Research 48:22, pages 12900-12916.
Crossref
Sophie Kellaway, Paulynn S. Chin, Farnaz Barneh, Constanze Bonifer & Olaf Heidenreich. (2020) t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming. Cells 9:12, pages 2681.
Crossref
Liang Chen, Xiong Yang, Jun Zhao, Ming Xiong, Raya Almaraihah, Zhaohui Chen & Teng Hou. (2020) Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Paulynn Suyin Chin & Constanze Bonifer. (2020) Modelling t(8;21) acute myeloid leukaemia ‐ What have we learned?. MedComm 1:3, pages 260-269.
Crossref
Junichi Fukunaga, Yusuke Nomura, Yoichiro Tanaka, Hidetaka Torigoe, Yoshikazu Nakamura, Taiichi Sakamoto & Tomoko Kozu. (2020) A G‐quadruplex‐forming RNA aptamer binds to the MTG8 TAFH domain and dissociates the leukemic AML1‐MTG8 fusion protein from DNA. FEBS Letters 594:21, pages 3477-3489.
Crossref
Monica Nafria, Peter Keane, Elizabeth S. Ng, Edouard G. Stanley, Andrew G. Elefanty & Constanze Bonifer. (2020) Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells. Cell Reports 31:8, pages 107691.
Crossref
Chun Guo, Jian Li, Nickolas Steinauer, Madeline Wong, Brent Wu, Alexandria Dickson, Markus Kalkum & Jinsong Zhang. (2020) Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1–ETO–dependent transcription in t(8;21) AML. Journal of Biological Chemistry 295:13, pages 4212-4223.
Crossref
Caroline Schoenherr, Katharina Wohlan, Iris Dallmann, Andreas Pich, Jan Hegermann, Arnold Ganser, Denise Hilfiker-Kleiner, Olaf Heidenreich, Michaela Scherr & Matthias Eder. (2019) Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase. PLOS ONE 14:12, pages e0225977.
Crossref
Alessandro Beghini. (2019) Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription. Cancers 11:12, pages 1973.
Crossref
Julie A. I. Thoms, Dominik Beck & John E. Pimanda. (2019) Transcriptional networks in acute myeloid leukemia. Genes, Chromosomes and Cancer 58:12, pages 859-874.
Crossref
Ye Xu, Na Man, Daniel Karl, Concepcion Martinez, Fan Liu, Jun Sun, Camilo Jose Martinez, Gloria Mas Martin, Felipe Beckedorff, Fan Lai, Jingyin Yue, Alejandro Roisman, Sarah Greenblatt, Stephanie Duffort, Lan Wang, Xiaojian Sun, Maria Figueroa, Ramin Shiekhattar & Stephen Nimer. (2019) TAF1 plays a critical role in AML1-ETO driven leukemogenesis. Nature Communications 10:1.
Crossref
Anton M. Jetten. (2019) Emerging Roles of GLI-Similar Krüppel-like Zinc Finger Transcription Factors in Leukemia and Other Cancers. Trends in Cancer 5:9, pages 547-557.
Crossref
Anetta Ptasinska, Anna Pickin, Salam A. Assi, Paulynn Suyin Chin, Luke Ames, Roberto Avellino, Stefan Gröschel, Ruud Delwel, Peter N. Cockerill, Cameron S. Osborne & Constanze Bonifer. (2019) RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction. Cell Reports 28:12, pages 3022-3031.e7.
Crossref
Sarah P. Short, Caitlyn W. Barrett, Kristy R. Stengel, Frank L. Revetta, Yash A. Choksi, Lori A. Coburn, Mary K. Lintel, Elizabeth M. McDonough, M. Kay Washington, Keith T. Wilson, Egor Prokhortchouk, Xi Chen, Scott W. Hiebert, Albert B. Reynolds & Christopher S. Williams. (2019) Kaiso is required for MTG16-dependent effects on colitis-associated carcinoma. Oncogene 38:25, pages 5091-5106.
Crossref
Deli Hong, Andrew J. Fritz, Jonathan A. Gordon, Coralee E. Tye, Joseph R. Boyd, Kirsten M. Tracy, Seth E. Frietze, Frances E. Carr, Jeffrey A. Nickerson, Andre J. Van Wijnen, Anthony N. Imbalzano, Sayyed K. Zaidi, Jane B. Lian, Janet L. Stein & Gary S. Stein. (2018) RUNX1‐dependent mechanisms in biological control and dysregulation in cancer. Journal of Cellular Physiology 234:6, pages 8597-8609.
Crossref
Susu Zhang, Yue Zhao, Tiffany M. Heaster, Melissa A. Fischer, Kristy R. Stengel, Xiaofan Zhou, Haley Ramsey, Ming‐Ming Zhou, Michael R. Savona, Melissa C. Skala & Scott W. Hiebert. (2018) BET inhibitors reduce cell size and induce reversible cell cycle arrest in AML. Journal of Cellular Biochemistry 120:5, pages 7309-7322.
Crossref
Mylène Gerritsen, Guoqiang YiEsther TijchonJorren KusterJan Jacob Schuringa, Joost H. A. MartensEdo Vellenga. (2019) RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs. Blood Advances 3:3, pages 320-332.
Crossref
Emiel van der Kouwe & Philipp Staber. (2019) RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia. International Journal of Molecular Sciences 20:2, pages 350.
Crossref
Na LiuJunhong SongYangyang XieXiao-Lin WangBowen RongNa ManMeng-Meng ZhangQunling ZhangFei-Fei GaoMei-Rong DuYing ZhangJian ShenChun-Hui XuCheng-Long HuJi-Chuan WuPing LiuYuan-Liang ZhangYin-Yin XiePing LiuJin-Yan Huang, Qiu-Hua HuangFei LanShuhong ShenStephen D. NimerZhu ChenSai-Juan ChenRobert G. Roeder, Lan WangXiao-Jian Sun. (2018) Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis. Proceedings of the National Academy of Sciences 116:3, pages 890-899.
Crossref
Vered Yahalom, Nir Pillar, Yingying Zhao, Shirley Modan, Mingyan Fang, Lydia Yosephi, Orna Asher, Eilat Shinar, Gershon Celniker, Haike Resnik-Wolf, Yael Brantz, Hagit Hauschner, Nurit Rosenberg, Le Cheng, Noam Shomron & Elon Pras. (2018) SMYD1 is the underlying gene for the AnWj-negative blood group phenotype . European Journal of Haematology 101:4, pages 496-501.
Crossref
Natalia Martinez-Soria, Lynsey McKenzie, Julia Draper, Anetta Ptasinska, Hasan Issa, Sandeep Potluri, Helen J. Blair, Anna Pickin, Asmida Isa, Paulynn Suyin Chin, Ricky Tirtakusuma, Daniel Coleman, Sirintra Nakjang, Salam Assi, Victoria Forster, Mojgan Reza, Ed Law, Philip Berry, Dorothee Mueller, Cameron Osborne, Alex Elder, Simon N. Bomken, Deepali Pal, James M. Allan, Gareth J. Veal, Peter N. Cockerill, Christian Wichmann, Josef Vormoor, Georges Lacaud, Constanze Bonifer & Olaf Heidenreich. (2018) The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation. Cancer Cell 34:4, pages 626-642.e8.
Crossref
Justin Loke, Paulynn Suyin Chin, Peter Keane, Anna Pickin, Salam A. Assi, Anetta Ptasinska, Maria Rosaria Imperato, Peter N. Cockerill & Constanze Bonifer. (2018) C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia. Blood Advances 2:3, pages 271-284.
Crossref
Amir Hosseini & Saverio Minucci. 2018. Epigenetics in Human Disease. Epigenetics in Human Disease 141 217 .
J. N. Nichol, M. Kinal & W. H. MillerJr.Jr.. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 161 177 .
Kathryn S. Potts & Teresa V. Bowman. (2017) Modeling Myeloid Malignancies Using Zebrafish. Frontiers in Oncology 7.
Crossref
V N Thiel, B D Giaimo, P Schwarz, K Soller, V Vas, M Bartkuhn, T J Blätte, K Döhner, L Bullinger, T Borggrefe, H Geiger & F Oswald. (2017) Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation. Leukemia 31:11, pages 2491-2502.
Crossref
Raman Sood, Yasuhiko Kamikubo & Paul Liu. (2017) Role of RUNX1 in hematological malignancies. Blood 129:15, pages 2070-2082.
Crossref
Nickolas Steinauer, Chun Guo & Jinsong Zhang. (2017) Emerging Roles of MTG16 in Cell-Fate Control of Hematopoietic Stem Cells and Cancer. Stem Cells International 2017, pages 1-12.
Crossref
Shan Lin, James C. Mulloy & Susumu Goyama. 2017. RUNX Proteins in Development and Cancer. RUNX Proteins in Development and Cancer 151 173 .
Ryo Amano, Kenta Takada, Yoichiro Tanaka, Yoshikazu Nakamura, Gota Kawai, Tomoko Kozu & Taiichi Sakamoto. (2016) Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein. Biochemistry 55:45, pages 6221-6229.
Crossref
Kevin A. LinkShan LinMahesh ShresthaMelissa BowmanMark WunderlichClara D. BloomfieldGang Huang & James C. Mulloy. (2016) Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation. Proceedings of the National Academy of Sciences 113:32, pages 9075-9080.
Crossref
Jian Li, Chun Guo, Nickolas Steinauer & Jinsong Zhang. (2016) New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins. Frontiers in Biology 11:4, pages 285-304.
Crossref
Xiangli Ye, Yu Qian, Qian Wang, Wuzhou Yuan, Xiaoyang Mo, Yongqing Li, Zhigang Jiang, Wei Xu, Yun Deng, Yongqi Wan, Xiongwei Fan, Xiushan Wu & Yuequn Wang. (2016) SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis. PLOS ONE 11:1, pages e0146468.
Crossref
B A Vishwakarma, N Nguyen, H Makishima, N Hosono, K O Gudmundsson, V Negi, K Oakley, Y Han, B Przychodzen, J P Maciejewski & Y Du. (2015) Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development. Leukemia 30:1, pages 200-208.
Crossref
N. Bansal, G. David, E. Farias & S. Waxman. 2016. 113 135 .
Mo Chen, Nan Zhu, Xiaochuan Liu, Benoit Laurent, Zhanyun Tang, Rowena Eng, Yang Shi, Scott A. Armstrong & Robert G. Roeder. (2015) JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors. Genes & Development 29:20, pages 2123-2139.
Crossref
Kate H. Brettingham-Moore, Phillippa C. Taberlay & Adele F. Holloway. (2015) Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia. Frontiers in Immunology 6.
Crossref
Shinsuke Mizutani, Tatsushi Yoshida, Xinyang Zhao, Stephen D. Nimer, Masafumi Taniwaki & Tsukasa Okuda. (2015) Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis. British Journal of Haematology 170:6, pages 859-873.
Crossref
Gao Hong-Wei, Liu Lan, Xing De-Guo, Liu Zhong-Hao, Ren Peng, Li Zhi-Qiang, Shan Guo-Qiang & Gong Ming-Zhi. (2015) NCoR negatively regulates adipogenic differentiation of mesenchymal stem cells. In Vitro Cellular & Developmental Biology - Animal 51:7, pages 749-758.
Crossref
Parveen Kumar, Urban Gullberg, Inge Olsson & Ram Ajore. (2015) Myeloid Translocation Gene-16 Co-Repressor Promotes Degradation of Hypoxia-Inducible Factor 1. PLOS ONE 10:5, pages e0123725.
Crossref
K Ponnusamy, N Kohrs, A Ptasinska, S A Assi, T Herold, W Hiddemann, J Lausen, C Bonifer, R Henschler & C Wichmann. (2015) RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1. Oncogenesis 4:4, pages e146-e146.
Crossref
Shenika V. Poindexter, Vishruth K. Reddy, Mukul K. MittalAmanda M. Williams, M. Kay Washington, Elizabeth Harris, Amanda MahScott W. Hiebert, Kshipra SinghRupesh Chaturvedi, Keith T. Wilson, P. Kay LundChristopher S. Williams. (2015) Transcriptional corepressor MTG16 regulates small intestinal crypt proliferation and crypt regeneration after radiation-induced injury. American Journal of Physiology-Gastrointestinal and Liver Physiology 308:6, pages G562-G571.
Crossref
Jonathan I. Sive & Berthold Göttgens. (2014) Transcriptional network control of normal and leukaemic haematopoiesis. Experimental Cell Research 329:2, pages 255-264.
Crossref
Jung-Hyun Kim & Eun-Young Erin Ahn. (2014) Transcript variants of RUNX1T1: New insight into t(8;21)-positive leukemia. Leukemia Research 38:9, pages 1018-1019.
Crossref
Michael BotsInge VerbruggeBenjamin P. MartinJessica M. SalmonMargherita GhisiAdele BakerKym StanleyJake ShorttGert J. OssenkoppeleJohannes ZuberAmy R. RappaportPeter Atadja, Scott W. LoweRicky W. Johnstone. (2014) Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. Blood 123:9, pages 1341-1352.
Crossref
Nimmi Baby, Yali Li, Eng-Ang Ling, Jia Lu & S. Thameem Dheen. (2014) Runx1t1 (Runt-Related Transcription Factor 1; Translocated to, 1) Epigenetically Regulates the Proliferation and Nitric Oxide Production of Microglia. PLoS ONE 9:2, pages e89326.
Crossref
ZHI-HUA ZHANG, CHANG-LAI HAO, PENG LIU, XIA TIAN, LI-HONG WANG, LEI ZHAO & CUI-MIN ZHU. (2014) Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi-1 leukemia cells. Molecular Medicine Reports 9:2, pages 443-449.
Crossref
Chien-Hung Gow, Chun Guo, David Wang, Qiande Hu & Jinsong Zhang. (2014) Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways. Nucleic Acids Research 42:1, pages 137-152.
Crossref
Jesús Duque-Afonso, Michael Lübbert & Michael L. Cleary. 2014. Epigenetic Therapy of Cancer. Epigenetic Therapy of Cancer 121 144 .
Russell C. DeKelver, Benjamin Lewin, Kentson Lam, Yukiko Komeno, Ming Yan, Chandler Rundle, Miao-Chia Lo & Dong-Er Zhang. (2013) Cooperation between RUNX1-ETO9a and Novel Transcriptional Partner KLF6 in Upregulation of Alox5 in Acute Myeloid Leukemia. PLoS Genetics 9:10, pages e1003765.
Crossref
Xiao-Jian Sun, Zhanxin Wang, Lan Wang, Yanwen Jiang, Nils Kost, T. David Soong, Wei-Yi Chen, Zhanyun Tang, Tomoyoshi Nakadai, Olivier Elemento, Wolfgang Fischle, Ari Melnick, Dinshaw J. Patel, Stephen D. Nimer & Robert G. Roeder. (2013) A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis. Nature 500:7460, pages 93-97.
Crossref
Russell C. DeKelverMing YanEun-Young AhnWei-Jong ShiaNancy A. Speck & Dong-Er Zhang. (2013) Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential. Blood 121:18, pages 3714-3717.
Crossref
Melissa MalvaezSusan C. McQuown, George A. RoggeMariam AstarabadiVincent Jacques, Samantha Carreiro, James R. Rusche & Marcelo A. Wood. (2013) HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proceedings of the National Academy of Sciences 110:7, pages 2647-2652.
Crossref
Fatiha Kateb, Helene Perrin, Konstantinos Tripsianes, Peijian Zou, Roberta Spadaccini, Matthew Bottomley, Titus M. Franzmann, Johannes Buchner, Stephane Ansieau & Michael Sattler. (2013) Structural and Functional Analysis of the DEAF-1 and BS69 MYND Domains. PLoS ONE 8:1, pages e54715.
Crossref
Stefano Rossetti & Nicoletta Sacchi. (2013) RUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis. International Journal of Molecular Sciences 14:1, pages 1566-1588.
Crossref
Yvonne Bartel, Manuel Grez & Christian Wichmann. (2013) Interference with RUNX1/ETO Leukemogenic Function by Cell-Penetrating Peptides Targeting the NHR2 Oligomerization Domain. BioMed Research International 2013, pages 1-14.
Crossref
Ping Lu, Bruce S. Hostager, Paul B. Rothman & John D. Colgan. 2013. Gene Regulation. Gene Regulation 365 383 .
Jessica N. Nichol, Sarit Assouline & Wilson H. Miller. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 177 198 .
Caitlyn W. Barrett, J. Joshua Smith, Lauren C. Lu, Nicholas Markham, Kristy R. Stengel, Sarah P. Short, Baolin Zhang, Aubrey A. Hunt, Barbara M. Fingleton, Robert H. Carnahan, Michael E. Engel, Xi Chen, R. Daniel Beauchamp, Keith T. Wilson, Scott W. Hiebert, Albert B. Reynolds & Christopher S. Williams. (2012) Kaiso Directs the Transcriptional Corepressor MTG16 to the Kaiso Binding Site in Target Promoters. PLoS ONE 7:12, pages e51205.
Crossref
Xiangning Zhang, Hui Liu, Binbin Li, Peichun Huang, Jianyong Shao & Zhiwei He. (2012) Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter. BMC Cancer 12:1.
Crossref
E. N. Markova, N. V. Petrova, S. V. Razin & O. L. Kantidze. (2012) Transcription factor RUNX1. Molecular Biology 46:6, pages 755-767.
Crossref
Megan A. Hatlen, Lan Wang & Stephen D. Nimer. (2012) AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches. Frontiers of Medicine 6:3, pages 248-262.
Crossref
Miao-Chia LoLuke F. PetersonMing YanXiuli CongFulai JinWei-Jong ShiaShinobu MatsuuraEun-Young AhnYukiko KomenoMinh LyHans B. OmmenI-Ming Chen, Peter HoklandCheryl L. Willman, Bing RenDong-Er Zhang. (2012) Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML. Blood 120:7, pages 1473-1484.
Crossref
A Ptasinska, S A Assi, D Mannari, S R James, D Williamson, J Dunne, M Hoogenkamp, M Wu, M Care, H McNeill, P Cauchy, M Cullen, R M Tooze, D G Tenen, B D Young, P N Cockerill, D R Westhead, O Heidenreich & C Bonifer. (2012) Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia 26:8, pages 1829-1841.
Crossref
Tanja A. Gruber & James R. Downing. 2013. Childhood Leukemias. Childhood Leukemias 204 238 .
A Maiques-Diaz, F S Chou, M Wunderlich, G Gómez-López, F V Jacinto, S Rodriguez-Perales, M J Larrayoz, M J Calasanz, J C Mulloy, J C Cigudosa & S Alvarez. (2012) Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs. Leukemia 26:6, pages 1329-1337.
Crossref
Jasmine Zain. (2012) Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma. Hematology/Oncology Clinics of North America 26:3, pages 671-704.
Crossref
Michal Zapotocky, Ester Mejstrikova, Karel Smetana, Jan Stary, Jan Trka & Julia Starkova. (2012) Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically. Cancer Letters 319:2, pages 144-153.
Crossref
Wei-Jong ShiaAkiko J. OkumuraMing YanAli SarkeshikMiao-Chia LoShinobu MatsuuraYukiko KomenoXinyang Zhao, Stephen D. Nimer, John R. YatesIIIIIIDong-Er Zhang. (2012) PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential. Blood 119:21, pages 4953-4962.
Crossref
Melissa A Fischer, Isabel Moreno-Miralles, Aubrey Hunt, Brenda J Chyla & Scott W Hiebert. (2012) Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence. The EMBO Journal 31:6, pages 1494-1505.
Crossref
Heidi J. NickHyung-Gyoon KimChia-Wei ChangKevin W. Harris, Vishnu Reddy & Christopher A. Klug. (2012) Distinct classes of c-Kit–activating mutations differ in their ability to promote RUNX1-ETO–associated acute myeloid leukemia. Blood 119:6, pages 1522-1531.
Crossref
Peter J. Watson, Louise Fairall & John W.R. Schwabe. (2012) Nuclear hormone receptor co-repressors: Structure and function. Molecular and Cellular Endocrinology 348:2, pages 440-449.
Crossref
Ciro Mercurio, Simon Plyte & Saverio Minucci. 2012. Epigenetics in Human Disease. Epigenetics in Human Disease 53 87 .
Chi Keung ChengLibby LiSuk Hang ChengKitty NgNatalie P. H. ChanRosalina K. L. IpRaymond S. M. Wong, Matthew M. K. Shing, Chi Kong Li & Margaret H. L. Ng. (2011) Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia. Blood 118:25, pages 6638-6648.
Crossref
Yutaka Shima & Issay Kitabayashi. (2011) Deregulated transcription factors in leukemia. International Journal of Hematology 94:2, pages 134-141.
Crossref
Susumu Goyama & James C. Mulloy. (2011) Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects. International Journal of Hematology 94:2, pages 126-133.
Crossref
J Duque-Afonso, A Yalcin, T Berg, M Abdelkarim, O Heidenreich & M Lübbert. (2011) The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO. Oncogene 30:27, pages 3062-3072.
Crossref
Susan C. McQuown & Marcelo A. Wood. (2011) HDAC3 and the molecular brake pad hypothesis. Neurobiology of Learning and Memory 96:1, pages 27-34.
Crossref
Jesús Duque-Afonso, Leticia Solari, Aitomi Essig, Tobias Berg, Heike L. Pahl & Michael Lübbert. (2011) Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiation. British Journal of Haematology 153:5, pages 612-622.
Crossref
Ping Lu, Isaiah L. Hankel, Bruce S. Hostager, Julie A. Swartzendruber, Ann D. Friedman, Janet L. Brenton, Paul B. Rothman & John D. Colgan. (2011) The Developmental Regulator Protein Gon4l Associates with Protein YY1, Co-repressor Sin3a, and Histone Deacetylase 1 and Mediates Transcriptional Repression. Journal of Biological Chemistry 286:20, pages 18311-18319.
Crossref
Caitlyn W. Barrett, Barbara Fingleton, Amanda Williams, Wei Ning, Melissa A. Fischer, Mary K. Washington, Rupesh Chaturvedi, Keith T. Wilson, Scott W. Hiebert & Christopher S. Williams. (2011) MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model. Cancer Research 71:4, pages 1302-1312.
Crossref
Jasmeen Oberoi, Louise Fairall, Peter J Watson, Ji-Chun Yang, Zsolt Czimmerer, Thorsten Kampmann, Benjamin T Goult, Jacquie A Greenwood, John T Gooch, Bettina C Kallenberger, Laszlo Nagy, David Neuhaus & John W R Schwabe. (2011) Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery. Nature Structural & Molecular Biology 18:2, pages 177-184.
Crossref
I. Uribesalgo & L. Di Croce. (2011) Dynamics of epigenetic modifications in leukemia. Briefings in Functional Genomics 10:1, pages 18-29.
Crossref
Alysha K. Croker & Alison L. Allan. 2011. Cancer Stem Cells in Solid Tumors. Cancer Stem Cells in Solid Tumors 403 429 .
Manabi Fujiwara, Takayuki Teramoto, Takeshi Ishihara, Yasumi Ohshima & Steven L. McIntire. (2010) A Novel zf-MYND Protein, CHB-3, Mediates Guanylyl Cyclase Localization to Sensory Cilia and Controls Body Size of Caenorhabditis elegans. PLoS Genetics 6:11, pages e1001211.
Crossref
Neil I. Bower & Ian A. Johnston. (2010) Discovery and characterization of nutritionally regulated genes associated with muscle growth in Atlantic salmon. Physiological Genomics 42A:2, pages 114-130.
Crossref
A Gessner, M Thomas, P Garrido Castro, L Büchler, A Scholz, T H Brümmendorf, N Martinez Soria, J Vormoor, J Greil & O Heidenreich. (2010) Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT. Leukemia 24:10, pages 1751-1759.
Crossref
Lexun Wang, Xinbing Yu, Yabo Yang, Jingfang Chen, Dong Hu, Chuanhuan Deng, Xiao Yang, Xuchu Hu & Jin Xu. (2010) Molecular characterization and expression of the MYND-ZF gene from Clonorchis sinensis. Parasitology Research 107:5, pages 1249-1255.
Crossref
Takeshi Corpora, Liya Roudaia, Zaw Min Oo, Wei Chen, Ekaterina Manuylova, Xiongwei Cai, Michael J. Chen, Tomasz Cierpicki, Nancy A. Speck & John H. Bushweller. (2010) Structure of the AML1-ETO NHR3–PKA(RIIα) Complex and Its Contribution to AML1-ETO Activity. Journal of Molecular Biology 402:3, pages 560-577.
Crossref
Christian WichmannYvonne BeckerLinping Chen-WichmannVitali Vogel, Anna VojtkovaJulia HerglotzSandra MooreJoachim KochJörn LausenWerner Mäntele, Holger Gohlke & Manuel Grez. (2010) Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity. Blood 116:4, pages 603-613.
Crossref
Ciro Mercurio, Saverio Minucci & Pier Giuseppe Pelicci. (2010) Histone deacetylases and epigenetic therapies of hematological malignancies. Pharmacological Research 62:1, pages 18-34.
Crossref
D. Baskaran, P. V. Spirin & V. S. Prassolov. (2010) Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells. Molecular Biology 44:3, pages 369-379.
Crossref
Sheue-Yann ChengJack L. LeonardPaul J. Davis. (2010) Molecular Aspects of Thyroid Hormone Actions. Endocrine Reviews 31:2, pages 139-170.
Crossref
Jianjun Chen, Olatoyosi Odenike & Janet D. Rowley. (2010) Leukaemogenesis: more than mutant genes. Nature Reviews Cancer 10:1, pages 23-36.
Crossref
Kevin A. Link, Fu-Sheng Chou & James C. Mulloy. (2010) Core binding factor at the crossroads: Determining the fate of the HSC. Journal of Cellular Physiology 222:1, pages 50-56.
Crossref
Lan Wang, Gang Huang, Xinyang Zhao, Megan A. Hatlen, Ly Vu, Fan Liu & Stephen D. Nimer. (2009) Post-translational modifications of Runx1 regulate its activity in the cell. Blood Cells, Molecules, and Diseases 43:1, pages 30-34.
Crossref
Steven M. CorselloGiovanni RotiKenneth N. RossKwan T. ChowIlene Galinsky, Daniel J. DeAngelo, Richard M. Stone, Andrew L. KungTodd R. Golub & Kimberly Stegmaier. (2009) Identification of AML1-ETO modulators by chemical genomics. Blood 113:24, pages 6193-6205.
Crossref
Sangho ParkWei ChenTomasz CierpickiMarco TonelliXiongwei Cai, Nancy A. Speck & John H. Bushweller. (2009) Structure of the AML1-ETO eTAFH domain–HEB peptide complex and its contribution to AML1-ETO activity. Blood 113:15, pages 3558-3567.
Crossref
Serena Ghisletti, Wendy Huang, Kristen Jepsen, Chris Benner, Gary Hardiman, Michael G. Rosenfeld & Christopher K. Glass. (2009) Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes & Development 23:6, pages 681-693.
Crossref
Michael E. Engel & Scott W. Hiebert. 2010. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 127 147 .
Rakesh Singh Dhanda, Sofia Rondin Lindberg & Inge Olsson. (2008) The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues. BMC Molecular Biology 9:1.
Crossref
Eun-Young AhnMing YanOxana A. MalakhovaMiao-Chia LoAnita BoyapatiHans Beier Ommen, Robert HinesPeter Hokland & Dong-Er Zhang. (2008) Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis. Proceedings of the National Academy of Sciences 105:44, pages 17103-17108.
Crossref
Chi Keung ChengLibby LiSuk Hang ChengKin Mang LauNatalie P. H. ChanRaymond S. M. Wong, Matthew M. K. Shing, Chi Kong Li & Margaret H. L. Ng. (2008) Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia. Blood 112:8, pages 3391-3402.
Crossref
A M S Müller, J Duque, J A Shizuru & M Lübbert. (2008) Complementing mutations in core binding factor leukemias: from mouse models to clinical applications. Oncogene 27:44, pages 5759-5773.
Crossref
Yanfen Liu, Feng Wang, Huiyong Zhang, Hang He, Ligeng Ma & Xing Wang Deng. (2008) Functional characterization of the Arabidopsis ubiquitin-specific protease gene family reveals specific role and redundancy of individual members in development . The Plant Journal 55:5, pages 844-856.
Crossref
Liang-Nian Song & Edward P. Gelmann. (2008) Silencing Mediator for Retinoid and Thyroid Hormone Receptor and Nuclear Receptor Corepressor Attenuate Transcriptional Activation by the β-Catenin-TCF4 Complex. Journal of Biological Chemistry 283:38, pages 25988-25999.
Crossref
Elizabeth C. Thompson & Andrew A. Travers. (2008) A Drosophila Smyd4 Homologue Is a Muscle-Specific Transcriptional Modulator Involved in Development. PLoS ONE 3:8, pages e3008.
Crossref
Akiko J. Okumura, Luke F. Peterson, Fumihiko Okumura, Anita Boyapati & Dong-Er Zhang. (2008) t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression. Blood 112:4, pages 1392-1401.
Crossref
Tiffany E. Farmer, Christopher S. Williams, M. Kay Washington & Scott W. Hiebert. (2008) Inactivation of the p19ARF tumor suppressor affects intestinal epithelial cell proliferation and integrity. Journal of Cellular Biochemistry 104:6, pages 2228-2240.
Crossref
Michael Lübbert, Carsten Müller-Tidow, Wolf-Karsten Hofmann & H. Phillip Koeffler. (2008) Advances in the treatment of acute myeloid leukemia: From chromosomal aberrations to biologically targeted therapy. Journal of Cellular Biochemistry 104:6, pages 2059-2070.
Crossref
Peter Paschka. (2008) Core Binding Factor Acute Myeloid Leukemia. Seminars in Oncology 35:4, pages 410-417.
Crossref
Cynthia K. HahnKenneth N. RossIan M. WarringtonRalph Mazitschek, Cindy M. KanegaiRenee D. WrightAndrew L. KungTodd R. Golub & Kimberly Stegmaier. (2008) Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation. Proceedings of the National Academy of Sciences 105:28, pages 9751-9756.
Crossref
Rose M. Ko, Hyung-Gyoon Kim, Linda Wolff & Christopher A. Klug. (2008) Roles of p15Ink4b and p16Ink4a in myeloid differentiation and RUNX1-ETO-associated acute myeloid leukemia. Leukemia Research 32:7, pages 1101-1111.
Crossref
Elena Serrano, Maria J. Carnicer, Adriana Lasa, Vanesa Orantes, Jorge Pena, Salut Brunet, Anna Aventín, Jorge Sierra & Josep F. Nomdedéu. (2008) Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias. Leukemia Research 32:6, pages 944-953.
Crossref
Oliver H. Krämer, Sylvia Müller, Marc Buchwald, Sigrid Reichardt & Thorsten Heinzel. (2007) Mechanism for ubiquitylation of the leukemia fusion proteins AML1‐ETO and PML‐RARα. The FASEB Journal 22:5, pages 1369-1379.
Crossref
Srividya Bhaskara, Brenda J. Chyla, Joseph M. Amann, Sarah K. Knutson, David Cortez, Zu-Wen Sun & Scott W. Hiebert. (2008) Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control. Molecular Cell 30:1, pages 61-72.
Crossref
Martin Carroll. (2008) New role for AML1/ETO in leukemogenesis. Blood 111:4, pages 1752-1752.
Crossref
Lei Wang & Chih-Cheng Tsai. (2008) Atrophin Proteins: An Overview of a New Class of Nuclear Receptor Corepressors. Nuclear Receptor Signaling 6:1, pages nrs.06009.
Crossref
Rachael Nimmo & Alison Woollard. (2008) Worming out the biology of Runx. Developmental Biology 313:2, pages 492-500.
Crossref
Lawrence A. Wolfraim & John J. Letterio. 2008. Transforming Growth Factor-β in Cancer Therapy, Volume II. Transforming Growth Factor-β in Cancer Therapy, Volume II 181 202 .
Yiguo Hu & Shaoguang Li. 2008. Mouse Models of Human Blood Cancers. Mouse Models of Human Blood Cancers 21 43 .
A Tonks, L Pearn, M Musson, A Gilkes, K I Mills, A K Burnett & R L Darley. (2007) Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia 21:12, pages 2495-2505.
Crossref
Robert Hines, Anita Boyapati & Dong-Er Zhang. (2007) Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO. Blood Cells, Molecules, and Diseases 39:3, pages 297-306.
Crossref
P Karagianni & J Wong. (2007) HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 26:37, pages 5439-5449.
Crossref
Y Tabe, L Jin, R Contractor, D Gold, P Ruvolo, S Radke, Y Xu, Y Tsutusmi-Ishii, K Miyake, N Miyake, S Kondo, A Ohsaka, I Nagaoka, M Andreeff & M Konopleva. (2007) Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death & Differentiation 14:8, pages 1443-1456.
Crossref
Yufeng Wei, Shaohua Liu, Jörn Lausen, Christopher Woodrell, Seongeun Cho, Nikolaos Biris, Naohiro Kobayashi, Yu Wei, Shigeyuki Yokoyama & Milton H Werner. (2007) A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription. Nature Structural & Molecular Biology 14:7, pages 653-661.
Crossref
Yizhou Liu, Wei Chen, Justin Gaudet, Matthew D. Cheney, Liya Roudaia, Tomasz Cierpicki, Rachel C. Klet, Kari Hartman, Thomas M. Laue, Nancy A. Speck & John H. Bushweller. (2007) Structural Basis for Recognition of SMRT/N-CoR by the MYND Domain and Its Contribution to AML1/ETO's Activity. Cancer Cell 11:6, pages 483-497.
Crossref
Francesco Fazi, Giuseppe ZardoVania Gelmetti, Lorena Travaglini, Alberto Ciolfi, Luciano Di CroceAlessandro RosaIrene BozzoniFrancesco GrignaniFrancesco Lo-Coco, Pier Giuseppe PelicciClara Nervi. (2007) Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 109:10, pages 4432-4440.
Crossref
Christian Wichmann, Linping Chen, Markus Heinrich, Daniela Baus, Edith Pfitzner, Martin Zörnig, Oliver G. Ottmann & Manuel Grez. (2007) Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells. Cancer Research 67:5, pages 2280-2289.
Crossref
G Yang, M A Thompson, S J Brandt & S W Hiebert. (2006) Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein. Oncogene 26:1, pages 91-101.
Crossref
Alan D. Friedman. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 27 42 .
Chen Ren, Shujun Liu, Kalpana Ghoshal, Pang-Hung Hsu, Samson T. Jacob, Guido Marcucci & Michael A. Freitas. (2007) Simultaneous metabolic labeling of cells with multiple amino acids: Localization and dynamics of histone acetylation and methylation. PROTEOMICS – Clinical Applications 1:1, pages 130-142.
Crossref
Natalia MeierSanja KrpicPatrick RodriguezJohn StrouboulisMaria MontiJeroen KrijgsveldMartin GeringRoger PatientArnd HostertFrank Grosveld. (2006) Novel binding partners of Ldb1 are required for haematopoietic development. Development 133:24, pages 4913-4923.
Crossref
Shao Jun Du, Josep Rotllant & Xungang Tan. (2006) Muscle-specific expression of the smyd1 gene is controlled by its 5.3-kb promoter and 5′-flanking sequence in zebrafish embryos . Developmental Dynamics 235:12, pages 3306-3315.
Crossref
J Dunne, C Cullmann, M Ritter, N Martinez Soria, B Drescher, S Debernardi, S Skoulakis, O Hartmann, M Krause, J Krauter, A Neubauer, B D Young & O Heidenreich. (2006) siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts. Oncogene 25:45, pages 6067-6078.
Crossref
Rachel Butler & Gillian P. Bates. (2006) Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nature Reviews Neuroscience 7:10, pages 784-796.
Crossref
Rainer Claus, Manfred Fliegauf, Michael Stock, Jesús A Duque, Mateusz Kolanczyk & Michael Lübbert. (2006) Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression . Journal of Leukocyte Biology 80:6, pages 1462-1472.
Crossref
E Reed-Inderbitzin, I Moreno-Miralles, S K Vanden-Eynden, J Xie, B Lutterbach, K L Durst-Goodwin, K S Luce, B J Irvin, M L Cleary, S J Brandt & S W Hiebert. (2006) RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription. Oncogene 25:42, pages 5777-5786.
Crossref
Tim Thomas, Lynn M. Corcoran, Raffi Gugasyan, Mathew P. Dixon, Thomas Brodnicki, Stephen L. Nutt, Donald Metcalf & Anne K. Voss. (2006) Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells. Genes & Development 20:9, pages 1175-1186.
Crossref
Jennifer J. Westendorf. (2006) Transcriptional co-repressors of Runx2. Journal of Cellular Biochemistry 98:1, pages 54-64.
Crossref
Yizhou Liu, Matthew D. Cheney, Justin J. Gaudet, Maksymilian Chruszcz, Stephen M. Lukasik, Daisuke Sugiyama, Jeff Lary, James Cole, Zbyszek Dauter, Wladek Minor, Nancy A. Speck & John H. Bushweller. (2006) The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell 9:4, pages 249-260.
Crossref
J Lausen, S Liu, M Fliegauf, M Lübbert & M H Werner. (2005) ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Oncogene 25:9, pages 1349-1357.
Crossref
M Ritter, D Kattmann, S Teichler, O Hartmann, M K R Samuelsson, A Burchert, J-P Bach, T D Kim, B Berwanger, C Thiede, R Jäger, G Ehninger, H Schäfer, N Ueki, M J Hayman, M Eilers & A Neubauer. (2006) Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 20:3, pages 437-443.
Crossref
Paul Kwon, Meier Hsu, Dalia Cohen & Peter Atadja. 2006. Histone Deacetylases. Histone Deacetylases 315 332 .
Alejandro Vaquero, Michael Scher & Danny Reinberg. 2006. Histone Deacetylases. Histone Deacetylases 23 60 .
Bojan Drobic, Katherine L. Dunn, Paula S. Espino & James R. Davie. 2006. Cancer: Cell Structures, Carcinogens and Genomic Instability. Cancer: Cell Structures, Carcinogens and Genomic Instability 25 47 .
Felix Francke, Friedrich Buck & Dietmar Bächner. (2005) MYND domain specific interaction of the melanin-concentrating hormone receptor 1 interacting zinc-finger protein with α- and β-tubulin. Biochemical and Biophysical Research Communications 334:4, pages 1292-1298.
Crossref
Stefano Rossetti, Leontine Van Unen, Ivo P Touw, André T Hoogeveen & Nicoletta Sacchi. (2005) Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation. Oncogene 24:34, pages 5325-5332.
Crossref
Joseph D. GrowneyHirokazu ShigematsuZhe LiBenjamin H. LeeJennifer AdelspergerRebecca RowanDavid P. CurleyJeffery L. KutokKoichi AkashiIfor R. WilliamsNancy A. SpeckD. Gary Gilliland. (2005) Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106:2, pages 494-504.
Crossref
Tetsuya Yamagata, Kazuhiro Maki & Kinuko Mitani. (2005) Runx1/AML1 in Normal and Abnormal Hematopoiesis. International Journal of Hematology 82:1, pages 1-8.
Crossref
A Melnick. (2005) Predicting the effect of transcription therapy in hematologic malignancies. Leukemia 19:7, pages 1109-1117.
Crossref
Jill Wildonger & Richard S. Mann. (2005) The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor. Development 132:10, pages 2263-2272.
Crossref
Karen Blyth, Ewan R. Cameron & James C. Neil. (2005) The runx genes: gain or loss of function in cancer. Nature Reviews Cancer 5:5, pages 376-387.
Crossref

Displaying 200 of 345 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.